A meta-analysis published in The Journal of Sexual Medicine reviewed data from two Phase III trials (INTIMATE SM 1 and 2) assessing the efficacy and safety of transdermal testosterone therapy in surgically postmenopausal women with hypoactive sexual desire disorder (HSDD) undergoing estrogen therapy. Women receiving testosterone experienced significant improvements in
